Education
About Us
Working with TipRanks
Follow Us
TOT BIOPHARM International Co. Ltd. (HK:1875)
:1875
RESEARCH TOOLSreports
Total Valuation
TOT BIOPHARM International Co. Ltd. has a market cap or net worth of HK$1.48B. The enterprise value is HK$1.23B.
Market CapHK$1.48B
Enterprise ValueHK$1.23B
Share Statistics
TOT BIOPHARM International Co. Ltd. has 772,787,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding772,787,900
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
TOT BIOPHARM International Co. Ltd.’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 3.54%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)3.54%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee1.80M
Profits Per Employee56.89K
Employee Count611
Asset Turnover0.73
Inventory Turnover2.91
Valuation Ratios
The current PE Ratio of TOT BIOPHARM International Co. Ltd. is 35.08. TOT BIOPHARM International Co. Ltd.’s PEG ratio is 0.33.
PE Ratio35.08
PS Ratio0.00
PB Ratio1.90
Price to Fair Value1.67
Price to FCF-7.52
Price to Operating Cash Flow22.61
PEG Ratio0.33
Income Statement
In the last 12 months, TOT BIOPHARM International Co. Ltd. had revenue of 1.10B and earned 34.76M in profits. Earnings per share was 0.05.
Revenue1.10B
Gross Profit782.43M
Operating Income41.25M
Pretax Income34.76M
Net Income34.76M
EBITDA84.96M
Earnings Per Share (EPS)0.05
Cash Flow
In the last 12 months, operating cash flow was 27.80M and capital expenditures -68.85M, giving a free cash flow of -41.05M billion.
Operating Cash Flow27.80M
Free Cash Flow-41.05M
Free Cash Flow per Share-0.05
Dividends & Yields
TOT BIOPHARM International Co. Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.53
52-Week Price Change-14.35%
50-Day Moving Average1.88
200-Day Moving Average1.87
Relative Strength Index (RSI)47.25
Average Volume (3m)147.41K
Important Dates
TOT BIOPHARM International Co. Ltd. upcoming earnings date is Aug 8, 2025, TBA Not Confirmed.
Last Earnings DateMar 11, 2025
Next Earnings DateAug 8, 2025
Ex-Dividend Date―
Financial Position
TOT BIOPHARM International Co. Ltd. as a current ratio of 1.79, with Debt / Equity ratio of 40.56%
Current Ratio1.79
Quick Ratio1.53
Debt to Market Cap0.32
Net Debt to EBITDA0.17
Interest Coverage Ratio0.00
Taxes
In the past 12 months, TOT BIOPHARM International Co. Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
TOT BIOPHARM International Co. Ltd. EV to EBITDA ratio is 14.52, with an EV/FCF ratio of 0.00.
EV to Sales1.12
EV to EBITDA14.52
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
TOT BIOPHARM International Co. Ltd. has HK$381.26M in cash and marketable securities with ¥395.47M in debt, giving a net cash position of HK$14.21M billion.
Cash & Marketable SecuritiesHK$381.26M
Total Debt¥395.47M
Net CashHK$14.21M
Net Cash Per ShareHK$0.02
Tangible Book Value Per ShareHK$1.00
Margins
Gross margin is 83.82%, with operating margin of 3.76%, and net profit margin of 3.16%.
Gross Margin83.82%
Operating Margin3.76%
Pretax Margin3.16%
Net Profit Margin3.16%
EBITDA Margin7.74%
EBIT Margin4.20%
Analyst Forecast
The average price target for TOT BIOPHARM International Co. Ltd. is HK$2.40, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$2.40
Price Target Upside25.65% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast38.48%
EPS Growth Forecast―